EARNING RECAP

Salesforce.com Inc

#CRM 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted 70c est. 55c $3.6B est. $3.56B -.97% ($156.97 closing price) $160.88 $154.80 sees Q1 adjusted EPS 60-61c est. 63c; sees FY20 revenue $15.95B-$16.05B est. $15.99B; says targeting revenue of $26B- $28B by FY23
Q2 adjusted 71c est. 47c $3.28B est. $3.23B -1.72% ($152.14 closing) $153.74 $149.50 raises FY19 adjusted EPS view to $2.50- $2.52 from $2.29- $2.31 est. $2.32; Raises FY19 revenue to $13.12B- $13.17B from $13.07B-$13.125B est. $13.13B
Q1 adjusted EPS 74c vs 46c $3.01B vs $2.94B +1.91% ($129.30 closing) $132.55 $127.84 FY19 adjusted EPS view to $2.29-$2.31 from $2.25-$2.27
#CRM 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted EPS 35c est. 34c $2.85B est. $2.81B +2.74% ($119.43 closing) $122.47 $118.05 sees FY19 adjusted EPS$2.02-$2.04 est. $1.74; Sees healthcare clients boosting growth
Q3 adjusted EPS 39c vs 37c $2.68B vs $2.65B -1.82% closed at $106.83 $107.49 $106.05 see Q4 adjusted EPS 32c-33c vs 34c
Q2 0.33c vs 0.31c 35c vs 34c 0.13% close at $93.07 $94.63 $91.30
Q1 28c vs 26c $2.39B vs $2.35B -0.40% @ $87.40 $91.00 $86.44 +2.62% @ $90.05. FY18 adjusted EPS view to $1.28-$1.30 from $1.27-$1.29. Notable selling following day

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.